Background/objective: Rheumatologic diseases encompass a group of disabling conditions that often require expensive clinical treatments and limit an individual's ability to work and maintain a steady income. The purpose of this study was to evaluate contemporary patterns of financial toxicity among patients with rheumatologic disease and assess for any associated demographic factors.
Methods: The cross-sectional National Health Interview Survey was queried from 2013 to 2018 for patients with rheumatologic disease.